These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 32640305)
1. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1. Li N; Xu Y; Yu T; Yao R; Chen J; Luo C; Wang J Gene; 2020 Oct; 757():144938. PubMed ID: 32640305 [TBL] [Abstract][Full Text] [Related]
2. [A novel compound heterozygous mutation in MYSM1 gene in a 1-month-old girl: a bone marrow failure syndrome 4 family survey and literature review]. Huang J; Zhan XY; Zhao AL; Wu B; Yang Y; Tan P; Wan LJ; Lu YH Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):129-134. PubMed ID: 33858043 [No Abstract] [Full Text] [Related]
3. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation. Le Guen T; Touzot F; André-Schmutz I; Lagresle-Peyrou C; France B; Kermasson L; Lambert N; Picard C; Nitschke P; Carpentier W; Bole-Feysot C; Lim A; Cavazzana M; Callebaut I; Soulier J; Jabado N; Fischer A; de Villartay JP; Revy P J Allergy Clin Immunol; 2015 Dec; 136(6):1619-1626.e5. PubMed ID: 26220525 [TBL] [Abstract][Full Text] [Related]
4. A novel compound heterozygous mutation of Zhan X; Zhao A; Wu B; Yang Y; Wan L; Tan P; Huang J; Lu Y Br J Biomed Sci; 2021 Oct; 78(4):239-243. PubMed ID: 33618624 [No Abstract] [Full Text] [Related]
5. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations. Bahrami E; Witzel M; Racek T; Puchałka J; Hollizeck S; Greif-Kohistani N; Kotlarz D; Horny HP; Feederle R; Schmidt H; Sherkat R; Steinemann D; Göhring G; Schlegelbeger B; Albert MH; Al-Herz W; Klein C J Allergy Clin Immunol; 2017 Oct; 140(4):1112-1119. PubMed ID: 28115216 [TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development. Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064 [TBL] [Abstract][Full Text] [Related]
7. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors. Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590 [TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review. Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625 [TBL] [Abstract][Full Text] [Related]
9. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction. Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579 [TBL] [Abstract][Full Text] [Related]
10. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks. Mathias B; O'Leary D; Saucier N; Ahmad F; White LS; Russell L; Shinawi M; Smith MJ; Abraham RS; Cooper MA; Kitcharoensakkul M; Green AM; Bednarski JJ J Allergy Clin Immunol; 2024 Apr; 153(4):1113-1124.e7. PubMed ID: 38065233 [TBL] [Abstract][Full Text] [Related]
11. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance. Petrov JC; Nijnik A Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034 [TBL] [Abstract][Full Text] [Related]
12. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation. Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548 [TBL] [Abstract][Full Text] [Related]
13. MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. Luan R; He M; Li H; Bai Y; Wang A; Sun G; Zhou B; Wang M; Wang C; Wang S; Zeng K; Feng J; Lin L; Wei Y; Kato S; Zhang Q; Zhao Y EMBO Mol Med; 2024 Jan; 16(1):10-39. PubMed ID: 38177530 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1. Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447 [TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression. Xu Z; Qin Q; Wang Y; Zhang H; Liu S; Li X; Chen Y; Wang Y; Ruan H; He W; Zhang T; Yan X; Wang C; Xu D; Jiang X Cell Death Dis; 2024 Feb; 15(2):129. PubMed ID: 38342917 [TBL] [Abstract][Full Text] [Related]
16. Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma. Lin YH; Wang H; Fiore A; Förster M; Tung LT; Belle JI; Robert F; Pelletier J; Langlais D; Nijnik A J Cell Mol Med; 2021 Jul; 25(14):7089-7094. PubMed ID: 34114734 [TBL] [Abstract][Full Text] [Related]
17. A novel synonymous ABCA3 variant identified in a Chinese family with lethal neonatal respiratory failure. Zhang W; Liu Z; Lin Y; Wang R; Xu J; He Y; Zhang F; Wu L; Chen D BMC Med Genomics; 2021 Oct; 14(1):256. PubMed ID: 34715861 [TBL] [Abstract][Full Text] [Related]
18. A novel SCN9A splicing mutation in a compound heterozygous girl with congenital insensitivity to pain, hyposmia and hypogeusia. Marchi M; Provitera V; Nolano M; Romano M; Maccora S; D'Amato I; Salvi E; Gerrits M; Santoro L; Lauria G J Peripher Nerv Syst; 2018 Sep; 23(3):202-206. PubMed ID: 29978519 [TBL] [Abstract][Full Text] [Related]
19. MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts. Alsultan A; Shamseldin HE; Osman ME; Aljabri M; Alkuraya FS Blood; 2013 Nov; 122(23):3844-5. PubMed ID: 24288411 [No Abstract] [Full Text] [Related]
20. A Synonymous Variant c.579A>G in the ETFDH Gene Caused Exon Skipping in a Patient With Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report. Hu G; Zeng J; Wang C; Zhou W; Jia Z; Yang J; Zheng B Front Pediatr; 2020; 8():118. PubMed ID: 32292771 [No Abstract] [Full Text] [Related] [Next] [New Search]